WJ-Pure

N/A

Report date: 2024/09/20 20:00:41

Base Information

Drug NameWJ-Pure
Drug Alias NameWJ-PURE
ClassificationBiologics
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, AdultPulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVitti Labs LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVitti Labs LLC
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, AdultPulmonary Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A